These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19823804)
21. Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers. Zedkova L; Coupland NJ; Man GC; Dinsa G; Sanghera G Depress Anxiety; 2003; 17(2):78-87. PubMed ID: 12621596 [TBL] [Abstract][Full Text] [Related]
22. Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females. Bell EC; Baker GB; Poag C; Bellavance F; Khudabux J; Le Mellédo JM Psychopharmacology (Berl); 2004 Mar; 172(3):248-54. PubMed ID: 14712334 [TBL] [Abstract][Full Text] [Related]
23. Diminished serotonergic functioning in hostile children with ADHD: tryptophan depletion increases behavioural inhibition. Zepf FD; Holtmann M; Stadler C; Demisch L; Schmitt M; Wöckel L; Poustka F Pharmacopsychiatry; 2008 Mar; 41(2):60-5. PubMed ID: 18311686 [TBL] [Abstract][Full Text] [Related]
24. Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers. Miller HE; Deakin JF; Anderson IM Br J Psychiatry; 2000 Feb; 176():182-8. PubMed ID: 10755058 [TBL] [Abstract][Full Text] [Related]
25. The effect of Korean-group cognitive behavioural therapy among patients with panic disorder in clinic settings. Choi YS; Lee EJ; Cho Y J Psychiatr Ment Health Nurs; 2017 Feb; 24(1):28-40. PubMed ID: 27774709 [TBL] [Abstract][Full Text] [Related]
26. Treatment of major depression in the context of panic disorder. Woody S; McLean PD; Taylor S; Koch WJ J Affect Disord; 1999 May; 53(2):163-74. PubMed ID: 10360411 [TBL] [Abstract][Full Text] [Related]
27. Serotonergic functioning and trait-impulsivity in attention-deficit/hyperactivity-disordered boys (ADHD): influence of rapid tryptophan depletion. Zepf FD; Stadler C; Demisch L; Schmitt M; Landgraf M; Poustka F Hum Psychopharmacol; 2008 Jan; 23(1):43-51. PubMed ID: 17926336 [TBL] [Abstract][Full Text] [Related]
28. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder. Argyropoulos SV; Hood SD; Adrover M; Bell CJ; Rich AS; Nash JR; Rich NC; Witchel HJ; Nutt DJ Biol Psychiatry; 2004 Oct; 56(7):503-9. PubMed ID: 15450786 [TBL] [Abstract][Full Text] [Related]
29. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. Barlow DH; Gorman JM; Shear MK; Woods SW JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116 [TBL] [Abstract][Full Text] [Related]
30. Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 2: Therapeutic effectiveness of a combined cognitive behavioural therapy and pharmacotherapy in treatment-resistant inpatients. Kolek A; Prasko J; Ociskova M; Holubova M; Vanek J; Grambal A; Slepecky M Neuro Endocrinol Lett; 2019 Dec; 40(6):271-283. PubMed ID: 32200586 [TBL] [Abstract][Full Text] [Related]
31. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder. Le Mellédo J; Jhangri GS; Lott P; Tait GR; McManus K; Geddes M; Chrapko W; Lara N Psychiatry Res; 2001 Apr; 101(3):237-42. PubMed ID: 11311926 [TBL] [Abstract][Full Text] [Related]
32. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder. Plag J; Gaudlitz K; Zschucke E; Yassouridis A; Pyrkosch L; Wittmann A; Holsboer F; Ströhle A Curr Pharm Des; 2012; 18(35):5619-26. PubMed ID: 22632477 [TBL] [Abstract][Full Text] [Related]
33. Increased response to a putative panicogenic nocebo administration in female patients with panic disorder. Ströhle A J Psychiatr Res; 2000; 34(6):439-42. PubMed ID: 11165311 [TBL] [Abstract][Full Text] [Related]
34. Cognitive behavioral therapy for postpartum panic disorder: a case series. Matsumoto K; Sato K; Hamatani S; Shirayama Y; Shimizu E BMC Psychol; 2019 Aug; 7(1):53. PubMed ID: 31439043 [TBL] [Abstract][Full Text] [Related]
35. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder. Roy-Byrne PP; Craske MG; Stein MB; Sullivan G; Bystritsky A; Katon W; Golinelli D; Sherbourne CD Arch Gen Psychiatry; 2005 Mar; 62(3):290-8. PubMed ID: 15753242 [TBL] [Abstract][Full Text] [Related]
36. Improvement in adult anxious and avoidant attachment during cognitive behavioral therapy for panic disorder. Zalaznik D; Weiss M; Huppert JD Psychother Res; 2019 Apr; 29(3):337-353. PubMed ID: 28826378 [TBL] [Abstract][Full Text] [Related]
38. Diminished central nervous 5-HT neurotransmission and mood self-ratings in children and adolescents with ADHD: no clear effect of rapid tryptophan depletion. Zepf FD; Holtmann M; Stadler C; Magnus S; Wöckel L; Poustka F Hum Psychopharmacol; 2009 Mar; 24(2):87-94. PubMed ID: 19226535 [TBL] [Abstract][Full Text] [Related]